Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (17)

2024

  1. A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity

    Neurobiology of Disease, Vol. 194

  2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

2023

  1. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

    Autophagy, Vol. 19, Núm. 7, pp. 1952-1981

2022

  1. A Neuron, Microglia, and Astrocyte Triple Co-culture Model to Study Alzheimer’s Disease

    Frontiers in Aging Neuroscience, Vol. 14

  2. Amyloid β / PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer´s disease

    Cell Death and Disease, Vol. 13, Núm. 3

  3. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers

    Parkinsonism and Related Disorders, Vol. 96, pp. 29-35

2021

  1. Effects of platelet-rich plasma on cellular populations of the central nervous system: The influence of donor age

    International Journal of Molecular Sciences, Vol. 22, Núm. 4, pp. 1-20

  2. Longitudinal evaluation of a novel BChE PET tracer as an early in vivo biomarker in the brain of a mouse model for Alzheimer disease

    Theranostics, Vol. 11, Núm. 13, pp. 6542-6559

  3. Polyphenols attenuate mitochondrial dysfunction induced by amyloid peptides

    Mitochondrial Physiology and Vegetal Molecules: Therapeutic Potential of Natural Compounds on Mitochondrial Health (Elsevier), pp. 317-337

2019

  1. APP depletion alters selective pre- and post-synaptic proteins

    Molecular and Cellular Neuroscience, Vol. 95, pp. 86-95

  2. Corrigendum to "Contribution of Neurons and Glial Cells to Complement-Mediated Synapse Removal during Development, Aging and in Alzheimer's Disease"

    Mediators of inflammation

2018

  1. Contribution of neurons and glial cells to complement-mediated synapse removal during development, aging and in Alzheimer's disease

    Mediators of Inflammation, Vol. 2018

  2. Mangiferin and morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by Amyloid Beta Oligomers

    Oxidative Medicine and Cellular Longevity, Vol. 2018

  3. P2X4 receptor controls microglia activation and favors remyelination in autoimmune encephalitis

    EMBO Molecular Medicine, Vol. 10, Núm. 8

  4. Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation

    Molecular Psychiatry, Vol. 23, Núm. 6, pp. 1530-1540

  5. Targeting beta-amyloid at the CSF: A new therapeutic strategy in Alzheimer's disease

    Frontiers in Aging Neuroscience, Vol. 10, Núm. APR

2016

  1. The endocytic pathway in microglia during health, aging and Alzheimer's disease

    Ageing Research Reviews, Vol. 32, pp. 89-103